Added to YB: 2015-10-05
Pitch date: 2015-10-05
MYGN:US [bullish]
Myriad Genetics, Inc.
-79.62%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Myriad Genetics, Inc., a molecular diagnostic testing and precision medicine company, develops and provides molecular tests.
Market Cap
$625.5M
Pitch Price
$34.30
Price Target
N/A
Dividend
N/A
EV/EBITDA
-78.01
P/E
-1.54
EV/Sales
0.84
Sector
Biotechnology
Category
N/A
Show full summary:
MYRIAD GENETICS INC MYGN:US
A summary for this pitch has not been created yet.
Read full article (0 min)